Evaluating Differences in Retention of siRNA Therapeutics on HALO 1000 Å OLIGO C18

Bonded Phase: OLIGO C18

Market Segment: Biopharmaceuticals

Particle Size: 2.7 µm

Pore Size: 1000 Å

Product Segment: BIOCLASS

Separation Mode: Reversed Phase

USP Number: L1